NEW, ADVANCED FORMULA THYRO-TABS^®!

As a response to new U.S.P. specifications, LLOYD has spent almost seven years, several million dollars and extensive resources to develop an improved levothyroxine tablet line. The results have evolved into a breakthrough formulation and packaging for Thyro-Tabs^®.

• The most stable, longest shelf-life product in the industry
• All nine strengths of tablets will initially have 21-month shelf life, 6 months longer than competitive brands.
• The price per tablet of the 120-count bottle is the same or less than what was charged for 1,000-count bottles.
• Label and insert are padded together on a round, hermetically-sealed, dispense-ready 120-count bottle.
• Our new formulation will be present in both humans and canine Thyro-Tabs^®.
• Only nine SKUs need to be inventoried by distributors and veterinarians, creating efficiencies in processes and costs of inventories.
• LLOYD assumes product liability when clinics send clients home with sealed LLOYD 120-count, dispense-ready bottles.

Click here to send us an email to get a free sample of the new formula and packaging today.

Markets branded pharmaceuticals and nutritional products for use by the veterinary profession.
Supplies a family of sterile injections for use in sedation, its reversal, and anesthesia of animals.
Dedicated to manufacturing products for the human pharmaceutical market.